To compare the diagnostic performance of the magnetic resonance (MR) imaging-based Prostate Imaging Reporting and Data System (PI-RADS) and a Likert scale in the detection of prostate cancer in a cohort of patients undergoing initial prostate biopsy.
This institutional review board-approved two-center prospective study included 118 patients with normal digital rectal examination (DRE) results but elevated prostate-specific antigen (PSA) levels (4-20 ng/mL) who were referred for initial prostate biopsies and had one suspicious (Likert scale score, Ն3) focus at prebiopsy 1.5-T multiparametric MR imaging performed with T2-weighted, diffusion-weighted [DW] , and dynamic contrast material-enhanced imaging. Targeted core biopsies and random systematic core biopsies were performed. The elementary unit for analysis was the core. Relationships were assessed by using the Mann-Whitney U test. Yates corrected and Pearson x 2 tests were used to evaluate categoric variables. A training set was randomly drawn to construct the receiver operating characteristic curves for the summed PI-RADS scores and for the Likert scale scores. The thresholds to recommend biopsy were obtained from the Youden J statistics and were tested in the remaining validation set in terms of predictive characteristics. Interobserver variability was analyzed by using weighed k statistics in a random set of 50 patients.
Results:
Higher T2-weighted, DW, and dynamic contrast-enhanced imaging PI-RADS scores were observed in areas that yielded cancer-positive cores. The percentage of positive cores increased with the sum of scores aggregated in five classes as follows: For summed PI-RADS scores of 3-5, the percentage of positive cores was 2.3%; for scores of 6-8, it was 5.8%; for scores of 9 or 10, it was 24.7%; for scores of 11 or 12, it was 51.8%; and for scores of 13-15, it was 72.1% (P for trend, ,.0001). For the threshold of summed PI-RADS scores of 9 or greater, sensitivity was 86.6%, specificity was 82.4%, the positive predictive value was 52.4%, the negative predictive value was 96.5%, and accuracy was 83.2%. The respective data for Likert scale scores of 3 or greater were 93.8%, 73.6%, 44.3%, 98.1%, and 73.3%. Good interobserver agreement was observed for the Likert scale (k = 0.80) and the summed PI-RADS (k = 0.73) scoring systems.
Conclusion:
PI-RADS provided the site-specific stratified risk of cancerpositive cores in biopsy-naive men with normal DRE results and elevated PSA levels. There was no significant difference between summed PI-RADS scores of 9 or greater and Likert scale scores of 3 or greater in the detection of cancer in the peripheral zone. W idespread prostate-specific antigen (PSA) testing and random sampling of the prostate gland by means of transrectal ultrasonographically (US)-guided biopsy (1) were instrumental in establishing prostate cancer as the most prevalent cancer in male patients in the United States, with more than 240 000 new cases expected in 2013 (2) . As acknowledged by the American Urological Association and the European Association of Urology (3, 4) this paradigm also resulted in the incidental detection of a silent reservoir of well-differentiated small-volume
Implication for Patient Care
n The results of the present study therefore support the role of multiparametric MR imaging in the initial evaluation of clinically suspected prostate cancer, where it could facilitate the detection of clinically important cancer foci. cancers of marginal clinical importance (5) . Because multiparametric magnetic resonance (MR) imaging allows noninvasive evaluation of the anatomy, angiogenesis, and cell density of the prostate gland (6, 7) , it could shift the paradigm from random sampling of the gland to targeted biopsies directed at clinically important cancers (8) .
Advances in Knowledge
One major impediment to the promotion of multiparametric MR imaging is the lack of standardization in the expression of results (9) . The European Society of Urogenital Radiology (ESUR) proposed use of the MR Prostate Imaging Reporting and Data System (PI-RADS) (10) , while the PREDICT (Prostate Diagnostic Imaging Consensus Meeting) panel recommended use of the five-point Likert scale (9) . Both systems reflected experts' opinions, as evidence-based recommendations could not yet be formulated.
Another limitation is that cancer detection is traditionally assessed on a patient-by-patient basis, where the absence of cancer can be suspected but not demonstrated in patients with negative transrectal US-guided biopsy results, while minute correlations between pathologic and multiparametric MR imaging findings are possible in other patients who undergo resection and whole-mount step-section pathologic examination, amounting to a classic verification bias. To deal with this problem, we took advantage of a commercial MR imaging-transrectal US fusion technology (11) (12) (13) that provides records of the spatial distribution of the cores within the prostate volume in the three-dimensional (3D) transrectal US and multiparametric MR imaging archives (11) .
Because most studies included patients with repeat biopsies who were likely to differ in terms of cancer prevalence, volume, and Gleason score from patients undergoing initial biopsy (14-16), we sought to compare the performance of the PI-RADS and a Likert scale in cancer detection in a cohort of patients undergoing initial prostate biopsy.
Materials and Methods

Patients
This prospective study, which was approved by the Comité de Protection des Personnes Sud-Ouest et Outre Mer, Bordeaux, France (CPP-DC2011/37), was conducted at two academic institutions. Informed consent was obtained from all patients.
Inclusion criteria were as follows: From June 2011 to December 2012, patients who were referred for initial biopsies for elevated PSA levels (4-20 ng/ mL) without findings suggestive of cancer at digital rectal examination (DRE) and who were offered multiparametric MR imaging. That is the diagnostic GENITOURINARY IMAGING: PI-RADS and Likert Scoring System: Multiparametric MR Imaging Validation Renard-Penna et al pathway proposed after negative biopsy results to patients in whom there is persistent clinical suspicion of prostate cancer (4).
Patients with a single focus of suspicion at multiparametric MR imaging (defined by a score Ն 3 on the fivepoint Likert scale [9] ) were offered protocol biopsies consisting of two or three targeted cores plus 12 random systematic cores obtained at the same session by using a deformable transrectal US-MR imaging image fusion system for biopsy guidance. Patients with suspicious findings at DRE, in whom the American Urological Association and the European Association of Urology guidelines recommend that additional cores should be obtained from the DRE suspect area (3, 4) , were excluded from the study.
Multiparametric MR Imaging
The MR imaging pulse sequences used followed the ESUR prostate MR imaging guidelines (10) and the guidelines of a European consensus meeting on multiparametric MR imaging (17) . Table 1 provides an ESUR-and START Consortium-compliant (18) description of the protocol. All patients were imaged in the supine position with a 1.5-T system, without an endorectal coil. Fast spin-echo T2-weighted images were first acquired in three planes. DW imaging with multiple b values and apparent diffusion coefficient (ADC) mapping were performed in the same planes as the T2-weighted sequences. Fatsaturated T1-weighted fast-field-echo images (echo-planar imaging) with a temporal resolution of 8.5-15 seconds were acquired before and after a bolus injection (20 mL/18 sec) of gadoterate meglumine (Dotarem; Guerbet, AulnaySous-Bois, France).
Prebiopsy MR Image Analysis
The objective was to validate inclusion (single lesion with a Likert scale score Ն 3) before protocol biopsies. Multiparametric MR imaging data were analyzed at workstations (institution 1: MR Workspace, Syngovia Siemens Healthcare, Erlangen, Germany; institution 2: Extended WorkSpace, Phillips Table 1 ESUR Healthcare, Best, the Netherlands) by one senior radiologist (R.R. or D.P., both with . 10 years of experience in prostate MR imaging) who was blinded to the PSA data. Pulse sequence images were analyzed independently and were scored according to the Likert scoring system (10). Focal signal decrease was first evaluated from base to apex on axial T2-weighted transverse sections, taking into account the zonal anatomy of the gland. Suspicious foci were then evaluated at DW sequences as areas showing restricted diffusion on axial transverse ADC maps and high signal intensity on high-b-value images. Focal enhancement after contrast medium injection was viewed on axial transverse dynamic contrast material-enhanced images. Regions of interest were manually drawn around areas of suspicion on the dynamic contrast-enhanced images to obtain perfusion curves.
MR Imaging/3D Real-time US Fusionguided Biopsy
Elastic fusion registration and MR imaging-guided transrectal biopsies were performed by using a commercially available U.S. Food and Drug Administration-approved MR imaging/3D transrectal US fusion-guided system (Urostation; Koelis, LaTronche, France) shown to allow precise 3D transrectal US targeting of a predefined location, recording of the core spatial location, and, ultimately, fusion of MR imagingDigital Imaging and Communications in Medicine (DICOM) archives and transrectal US images (11, (19) (20) (21) .
Briefly, MR imaging data were loaded in the Koelis workstation to achieve segmentation of the prostate volume (19) . Regions of interest were superimposed on areas that were suspicious at multiparametric MR imaging. Immediate prostate 3D transrectal US reconstruction was performed from one axial and two oblique acquisitions by using a motorized 3D end-fire endorectal probe (HD9; Philips Medical Systems, Best, the Netherlands). Three-dimensional transrectal US and MR imaging reconstructions were finally registered by means of an algorithm that controls the prostate deformations and changes in position at the time of transrectal US and biopsy (11) .
Given the rigid attachment of the biopsy guide to the probe, the position of a presumptive core could be modeled from the position of the probe. Repeated 3D transrectal US acquisitions then allowed modeling of the spatial distribution of a simulated core in relation to the target within the prostate volume. This function was systematically used for targeted cores to optimize the position of the probe before firing the biopsy gun.
Two targeted cores were obtained, followed by 12 sextant-random systematic laterally directed cores with no systematic transition zone cores. A third targeted core was obtained when the first two did not provide an adequate sample. For all cores, 3D transrectal US acquisition was repeated with the needle in situ to register its precise location within the prostate volume. At the end of the procedure, all cores, numbered consecutively, were referenced to the MR imaging and 3D transrectal US archives (Fig 1) .
Procedures were performed in conjunction by a senior radiologist in charge of target definition and prostate contouring (R.R. or D.P.) and a senior urologist (B.M. or P.M., both with . 20 years of experience in transrectal US-guided biopsy and > 200 fusion biopsies) who obtained the targeted and random biopsy cores. Cores were numbered and referred in microcassettes for pathologic examination by dedicated uropathologists who evaluated on a core-by-core basis the presence and length of cancer, as well as the Gleason primary and secondary grades.
Postprocedure Analysis
To acknowledge the diversity of multiparametric MR imaging features within the volumes sampled by random cores and the potential variations in accuracy for targeted cores, multiparametric MR imaging scores were assessed after the procedure on a coreby-core basis. To that purpose, the Koelis workstation was used to register the spatial distribution of the cores within the multiparametric MR imaging DICOM archives (19) . The multiparametric MR imaging features of the volumes sampled by the individual cores were then characterized at the corresponding workstation according to the PI-RADS system and the Likert scale (9,10) by a radiologist who was blinded to the pathologic results (R.R., D.P., E.B., or F.C., all with > 10 years
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Likert scale scores were defined as follows: A score of 1 indicated clinically important disease was highly unlikely to be present; a score of 2, clinically important cancer was unlikely to be present; a score of 3, the presence of clinically important cancer was equivocal; a score of 4, clinically important cancer was likely to be present; and a score of 5, clinically important disease was highly likely to be present. Cores were also annotated in terms of location in one of the 16 sectors in the European consensus panel diagram (17) .
Interobserver Agreement in Likert and PI-RADS Scores
Data in a random set of 50 patients (25 per institution) were drawn and scored independently by two radiologists (R.R. and D.P.) to evaluate interobserver variability.
Statistical Analysis
We present means and standard deviations or 95% confidence intervals (CIs) for continuous variables and percentages for categoric variables.
The elementary unit for analysis was the core, annotated with pathologic and multiparametric MR imaging characteristics assessed after the procedure. The relationship between scores and biopsy results was then assessed by using the nonparametric Mann-Whitney U test. Yates corrected and Pearson x 2 tests were used to evaluate the association between categoric variables. All P values were two sided. The level for statistical significance was set at P , .05.
A training set of two-thirds of the study population was randomly drawn to construct the empiric receiver operating characteristic (ROC) curves of the multiparametric MR imaging score systems. The thresholds to recommend a biopsy were estimated from the Youden J statistics (sensitivity + specificity 2 1) and were tested in terms of diagnostic performance in the remaining third of the population.
The characteristics of positive cores were compared according to the abovedefined thresholds. Adverse pathologic features in a core were defined according to Harnden et al (22) (24) . Because k scores not only reflect agreement but are also affected by the distribution of data across the scoring categories, the maximum possible k score was calculated for each sequence (25) . The proportion of agreement between the two readers was also presented.
Results
Population
There were 446 patients with PSA levels of 4-20 ng/mL who underwent multiparametric MR imaging. Of those, 245 (54.9%) had findings with a Likert scale score of 3 or higher. One hundred eighteen (26.5%) patients with one focus with a Likert scale score of 3 or higher were offered protocol biopsies. No patients declined biopsies.
Cancer was demonstrated in 69 (58.5%) of 118 patients. No differences in PSA level were demonstrated in relation to cancer diagnosis (PSA: 7.3 ng/ mL 6 2.9 vs 7.7 ng/mL 6 3.5 in patients without and those with cancer, respectively, P = .59). Core characteristics in the whole database (n = 1731) and according to biopsy technique are presented in Table 2 .
Cancer Detection at Multiparametric MR Imaging
In keeping with the primary biopsy setting of the present study, the majority of cores sampled the peripheral zone of the gland (1695 [97.9%] of 1731). Positive cores (n = 310) showed higher scores at T2-weighted, DW, and dynamic contrast-enhanced imaging than did negative cores (n = 1421) (T2-weighted imaging: 3.9 6 0.9 vs 2.3 6 0.9; DW imaging: 4.1 6 1.2 vs 1.8 6 1.1; and dynamic contrast-enhanced imaging: 3.9 6 1.3 vs 1.9 6 1.1; P , .00001 for all).
Conversely, the percentage of positive cores increased with T2-weighted imaging, DW imaging, and dynamic contrast-enhanced imaging scores (Fig 2) . A continuous increase in the proportion of positive cores was also observed when the sums of the scores at T2-weighted, DW, and dynamic contrastenhanced imaging (summed PI-RADS scores) were organized in five classes (mean and 95% CIs: 18 The balance between sensitivity and specificity for different thresholds was analyzed by using the ROC curves obtained in a randomly selected training set of 1119 cores amounting to 66% of the total cohort (Fig 4) . Both systems showed high areas under the ROC curve (AUCs): 0.89 (95% CI: 0.87, 0.91) and 0.90 (95% CI: 0.88, 0.92), suggesting clinically relevant predictive characteristics (26) . The Youden J statistics indicated threshold values of 9 for the summed PI-RADS scores and 3 for the Likert scale scores.
The characteristics of these thresholds were then validated in the 612 remaining cores (Table 3 ). Both systems exhibited excellent negative predictive values, but the summed PI-RADS scores showed a trend toward higher positive predictive value, at 52.4% (97
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Renard-Penna et al (Table  3) . Comparable detection results were observed with both systems. Detection yields of summed PI-RADS scores of 9 or greater and Likert scale scores of 3 or greater are presented in Table 4 .
Relationship between Multiparametric MR Imaging Findings and Adverse Features in Positive Cores
Higher T2-weighted, dynamic contrastenhanced, and DW imaging scores were observed in cores with summed Gleason scores of 7 or higher than in cores with summed Gleason scores of 6. Incremental scores also correlated with the length of cancer in the cores. As a consequence, significantly higher scores were demonstrated in cores that showed aggressive features according to the Harnden definition (Table 5) , as compared with cores that showed incidental findings. Conversely, the percentage of positive cores also increased with summed PI-RADS and Likert scores (Fig 3) .
Interobserver Agreement of Likert and PI-RADS Scores
As shown in Table 6 , good interobserver agreement (24) 
Discussion
In our study, the PI-RADS/ESUR scoring system for multiparametric MR imaging was validated to stratify the likelihood of cancer detection in a given location at initial biopsy. The cancer yield of biopsies increased proportionally with T2-weighted, DW, and dynamic contrastenhanced imaging scores, thereby confirming the relevance of the PI-RADS system in the stratification of cancer suspicion. Whatever sequence was used, the first two scoring incre- 
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Renard-Penna et al cores. The Likert scale rates the composite degree of suspicion of cancer, while with PI-RADS, the degree of suspicion of cancer with each pulse sequence type was scored independently. The structured and semiquantitative process of the PI-RADS may facilitate the training of radiologists and encourage the use of multiparametric MR imaging in prostate cancer diagnosis. In a cohort of patients scheduled for radical prostatectomy, Rosenkrantz et al (27) compared the score, suggesting that up to two-thirds of the cores could be spared with a minimal risk of overlooking cancer. Summed PI-RADS scores and Likert scores showed excellent capabilities in cancer detection, with AUCs in the 90% range. Implementing the proposed thresholds would avoid many cores being taken (69.9% [1210 of 1731] and 61.6% [1067 of 1731] of the cores had summed PI-RADS scores , 9 and Likert scale scores , 3, respectively) while overlooking few cancer Likert and PI-RADS scales in terms of accuracy among three senior radiologists. While both scales proved equally useful in the peripheral zone for detection of cancers larger than 3 mm in maximal diameter at prostatectomy (accuracy range: 88.2%-87.1% and 88.5%-89.6% for Likert and PI-RADS, respectively), the Likert scale showed better accuracy in the transition zone (accuracy range: 87.1%-92.6% and 70.0%-87.6%, respectively). This is consistent with previous reports GENITOURINARY IMAGING: PI-RADS and Likert Scoring System: Multiparametric MR Imaging Validation Renard-Penna et al state of overdetection of incidental cancers. However, insufficient evidence on the consistency of scoring between readers could impair the diffusion of the PI-RADS system. To our knowledge, a single prior study (30) that used in-bore 3.0-T MR imaging-guided biopsy as the reference standard addressed this question and showed that good interobserver agreement for cancer detection was observed between three senior radiologists. This level of performance was confirmed for 1.5-T MR imaging in the present study, where both the summed PI-RADS scores and the Likert scale scores achieved a good level of agreement between two senior radiologists (k = 0.73 respectively) values observed in the validation set are likely to be valuable in identifying suspicious locations, while allowing confident prediction of the absence of cancer (negative predictive value) would help to control unnecessary procedures. Comparable characteristics were reported for repeat biopsy (19) , supporting multiparametric MR imaging irrespective of the context of initial or repeat biopsy. Moreover, multiparametric MR imaging characteristics, as evaluated by using the PI-RADS and Likert scoring systems, also correlated with aggressive features in the cores, suggesting that diagnostic strategies based on multiparametric MR imaging findings could also be instrumental in controlling the current that showed that dynamic contrastenhanced imaging (28, 29) and DW imaging (29) carried no incremental value in the transition zone, which is characterized by foci of benign prostatic hyperplasia, dense fibrotic tissue, and increased vascularity. Assigning the same weight in interpretation to T2-weighted and DW or dynamic contrast-enhanced imaging might therefore be ill adapted to the specifics of this zone.
In GENITOURINARY IMAGING: PI-RADS and Likert Scoring System: Multiparametric MR Imaging Validation Renard-Penna et al and 0.80, respectively). As expected, the Likert scale that was part of the inclusion process (Likert Ն 3) showed better consistency in terms of k score and proportion of agreement than did the summed PI-RADS scores. While good interobserver agreement was observed for T2-weighted imaging (k = 0.61; agreement, 68%) and dynamic contrast-enhanced imaging (k = 0.71; agreement, 62%), only fair results were observed for DW imaging (k = 0.53; agreement, 58%). This might reflect imprecisions in the criteria used for DW image scoring. For instance, ADCs of the normal peripheral zone differ substantially between patients and, in patients with cancer, correlate with the ADCs of high-grade tumors (31) . They are also affected by the typical heterogeneity in density of prostate cancer (32) and by parameters related to the MR imaging unit. As a consequence, although it is a quantitative parameter, the use of fixed thresholds was not encouraged in the PI-RADS scoring system, which recommends evaluating reduction in ADC "compared with normal gland tissue," thereby allowing subjectivity in interpretation. Some subjectivity also applies when segmentation algorithms are used to research foci of high signal intensity in areas that show reduced ADCs to characterize the lesion as DW imaging score 4 (reduced ADC but isointense) or 5 (reduced ADC and hyperintensity on the high b value images). Of note, while in keeping with the minimal requirements of the ESUR guidelines (10) b values of 800-1000 sec/mm 2 were used in the present study, although better cancer discrimination and tumor-toperipheral zone contrast were recently reported with higher b values (eg, 2000 sec/mm 2 ) (33). Three limitations of our study should be acknowledged. First, in keeping with the primary biopsy setting of this study, few cores were taken in the transition zone. Second, this study focused only on patients with abnormal results at multiparametric MR imaging. It cannot therefore give any information on cancer detection in patients with normal imaging findings, nor can its results be used to obtain the false-negative rate of multiparametric MR imaging. Third, there was no control of potential mismatches between the actual spatial locations of the needle tracks and of the target and the locations displayed on the workstation. However, using the present registration system, Bauman et al (11) demonstrated excellent spatial accuracy (0.76 mm 6 0.52) during transrectal US-to-transrectal US registration, while Ukimura et al (12) measured in prostate phantoms a mean targeting error of 2.09 mm 6 1.28 during transrectal US-MR imaging registration.
In conclusion, the PI-RADS/ESUR scoring system for multiparametric MR imaging of the prostate was shown to provide clinically relevant stratification of the risk of showing prostate cancer in a given location in initial biopsies. The results of the present study therefore support the role of multiparametric MR imaging in the initial evaluation of prostate cancer suspicion, where it could facilitate the detection of clincially important cancer foci.
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